世界の線維芽細胞増殖因子（FGF）市場予測（～2028年）：FGF1、 FGF4、 FGF7、 FGF8、 FGF9、 FGF11、 FGF19

• 英文タイトル：Global Fibroblast Growth Factors (FGF) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8819 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

線維芽細胞増殖因子（FGF）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の線維芽細胞増殖因子（FGF）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 線維芽細胞増殖因子（FGF）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・FGF1、 FGF4、 FGF7、 FGF8、 FGF9、 FGF11、 FGF19 用途別セグメントは次のように区分されます。 ・循環器疾患、皮膚病、がん、その他 世界の線維芽細胞増殖因子（FGF）市場の主要な市場プレーヤーは以下のとおりです。 ・ProSpec、Thermo Fisher Scientific、Peprotech、Essex Bio-Technology、Corning、Lonza、Shanghai Tenry Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、線維芽細胞増殖因子（FGF）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な線維芽細胞増殖因子（FGF）メーカーの企業概要、2019年～2022年までの線維芽細胞増殖因子（FGF）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な線維芽細胞増殖因子（FGF）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別線維芽細胞増殖因子（FGF）の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの線維芽細胞増殖因子（FGF）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での線維芽細胞増殖因子（FGF）市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および線維芽細胞増殖因子（FGF）の産業チェーンを掲載しています。 ・第13、14、15章では、線維芽細胞増殖因子（FGF）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ProSpec、Thermo Fisher Scientific、Peprotech、Essex Bio-Technology、Corning、Lonza、Shanghai Tenry Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：FGF1、 FGF4、 FGF7、 FGF8、 FGF9、 FGF11、 FGF19 ・用途別分析2017年-2028年：循環器疾患、皮膚病、がん、その他 ・線維芽細胞増殖因子（FGF）の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・線維芽細胞増殖因子（FGF）のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・線維芽細胞増殖因子（FGF）のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・線維芽細胞増殖因子（FGF）の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・線維芽細胞増殖因子（FGF）の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Fibroblast Growth Factors (FGF) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fibroblast Growth Factors (FGF) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Cardiovascular Diseases accounting for % of the Fibroblast Growth Factors (FGF) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While FGF1 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fibroblast Growth Factors (FGF) include ProSpec, Thermo Fisher Scientific, Peprotech, Essex Bio-Technology, and Corning, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fibroblast Growth Factors (FGF) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
FGF1
FGF4
FGF7
FGF8
FGF9
FGF11
FGF19
Market segment by Application can be divided into
Cardiovascular Diseases
Skin Disease
Cancer
Other
The key market players for global Fibroblast Growth Factors (FGF) market are listed below:
ProSpec
Thermo Fisher Scientific
Peprotech
Essex Bio-Technology
Corning
Lonza
Shanghai Tenry Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fibroblast Growth Factors (FGF) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fibroblast Growth Factors (FGF), with price, sales, revenue and global market share of Fibroblast Growth Factors (FGF) from 2019 to 2022.
Chapter 3, the Fibroblast Growth Factors (FGF) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fibroblast Growth Factors (FGF) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fibroblast Growth Factors (FGF) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fibroblast Growth Factors (FGF).
Chapter 13, 14, and 15, to describe Fibroblast Growth Factors (FGF) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Fibroblast Growth Factors (FGF) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fibroblast Growth Factors (FGF) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 FGF1
1.2.3 FGF4
1.2.4 FGF7
1.2.5 FGF8
1.2.6 FGF9
1.2.7 FGF11
1.2.8 FGF19
1.3 Market Analysis by Application
1.3.1 Overview: Global Fibroblast Growth Factors (FGF) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cardiovascular Diseases
1.3.3 Skin Disease
1.3.4 Cancer
1.3.5 Other
1.4 Global Fibroblast Growth Factors (FGF) Market Size & Forecast
1.4.1 Global Fibroblast Growth Factors (FGF) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fibroblast Growth Factors (FGF) Sales in Volume (2017-2028)
1.4.3 Global Fibroblast Growth Factors (FGF) Price (2017-2028)
1.5 Global Fibroblast Growth Factors (FGF) Production Capacity Analysis
1.5.1 Global Fibroblast Growth Factors (FGF) Total Production Capacity (2017-2028)
1.5.2 Global Fibroblast Growth Factors (FGF) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fibroblast Growth Factors (FGF) Market Drivers
1.6.2 Fibroblast Growth Factors (FGF) Market Restraints
1.6.3 Fibroblast Growth Factors (FGF) Trends Analysis
2 Manufacturers Profiles
2.1 ProSpec
2.1.1 ProSpec Details
2.1.2 ProSpec Major Business
2.1.3 ProSpec Fibroblast Growth Factors (FGF) Product and Services
2.1.4 ProSpec Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Fibroblast Growth Factors (FGF) Product and Services
2.2.4 Thermo Fisher Scientific Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Peprotech
2.3.1 Peprotech Details
2.3.2 Peprotech Major Business
2.3.3 Peprotech Fibroblast Growth Factors (FGF) Product and Services
2.3.4 Peprotech Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Essex Bio-Technology
2.4.1 Essex Bio-Technology Details
2.4.2 Essex Bio-Technology Major Business
2.4.3 Essex Bio-Technology Fibroblast Growth Factors (FGF) Product and Services
2.4.4 Essex Bio-Technology Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Corning
2.5.1 Corning Details
2.5.2 Corning Major Business
2.5.3 Corning Fibroblast Growth Factors (FGF) Product and Services
2.5.4 Corning Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lonza
2.6.1 Lonza Details
2.6.2 Lonza Major Business
2.6.3 Lonza Fibroblast Growth Factors (FGF) Product and Services
2.6.4 Lonza Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai Tenry Pharmaceutical
2.7.1 Shanghai Tenry Pharmaceutical Details
2.7.2 Shanghai Tenry Pharmaceutical Major Business
2.7.3 Shanghai Tenry Pharmaceutical Fibroblast Growth Factors (FGF) Product and Services
2.7.4 Shanghai Tenry Pharmaceutical Fibroblast Growth Factors (FGF) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fibroblast Growth Factors (FGF) Breakdown Data by Manufacturer
3.1 Global Fibroblast Growth Factors (FGF) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fibroblast Growth Factors (FGF) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fibroblast Growth Factors (FGF)
3.4 Market Concentration Rate
3.4.1 Top 3 Fibroblast Growth Factors (FGF) Manufacturer Market Share in 2021
3.4.2 Top 6 Fibroblast Growth Factors (FGF) Manufacturer Market Share in 2021
3.5 Global Fibroblast Growth Factors (FGF) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fibroblast Growth Factors (FGF) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fibroblast Growth Factors (FGF) Market Size by Region
4.1.1 Global Fibroblast Growth Factors (FGF) Sales in Volume by Region (2017-2028)
4.1.2 Global Fibroblast Growth Factors (FGF) Revenue by Region (2017-2028)
4.2 North America Fibroblast Growth Factors (FGF) Revenue (2017-2028)
4.3 Europe Fibroblast Growth Factors (FGF) Revenue (2017-2028)
4.4 Asia-Pacific Fibroblast Growth Factors (FGF) Revenue (2017-2028)
4.5 South America Fibroblast Growth Factors (FGF) Revenue (2017-2028)
4.6 Middle East and Africa Fibroblast Growth Factors (FGF) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fibroblast Growth Factors (FGF) Sales in Volume by Type (2017-2028)
5.2 Global Fibroblast Growth Factors (FGF) Revenue by Type (2017-2028)
5.3 Global Fibroblast Growth Factors (FGF) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fibroblast Growth Factors (FGF) Sales in Volume by Application (2017-2028)
6.2 Global Fibroblast Growth Factors (FGF) Revenue by Application (2017-2028)
6.3 Global Fibroblast Growth Factors (FGF) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
7.2 North America Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
7.3 North America Fibroblast Growth Factors (FGF) Market Size by Country
7.3.1 North America Fibroblast Growth Factors (FGF) Sales in Volume by Country (2017-2028)
7.3.2 North America Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
8.2 Europe Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
8.3 Europe Fibroblast Growth Factors (FGF) Market Size by Country
8.3.1 Europe Fibroblast Growth Factors (FGF) Sales in Volume by Country (2017-2028)
8.3.2 Europe Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
9.2 Asia-Pacific Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
9.3 Asia-Pacific Fibroblast Growth Factors (FGF) Market Size by Region
9.3.1 Asia-Pacific Fibroblast Growth Factors (FGF) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fibroblast Growth Factors (FGF) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
10.2 South America Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
10.3 South America Fibroblast Growth Factors (FGF) Market Size by Country
10.3.1 South America Fibroblast Growth Factors (FGF) Sales in Volume by Country (2017-2028)
10.3.2 South America Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fibroblast Growth Factors (FGF) Sales by Type (2017-2028)
11.2 Middle East & Africa Fibroblast Growth Factors (FGF) Sales by Application (2017-2028)
11.3 Middle East & Africa Fibroblast Growth Factors (FGF) Market Size by Country
11.3.1 Middle East & Africa Fibroblast Growth Factors (FGF) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fibroblast Growth Factors (FGF) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fibroblast Growth Factors (FGF) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fibroblast Growth Factors (FGF)
12.3 Fibroblast Growth Factors (FGF) Production Process
12.4 Fibroblast Growth Factors (FGF) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fibroblast Growth Factors (FGF) Typical Distributors
13.3 Fibroblast Growth Factors (FGF) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---